Related references
Note: Only part of the references are listed.The changing face of hepatitis C in the new era of direct-acting antivirals
Vincent Soriano et al.
ANTIVIRAL RESEARCH (2013)
Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs
Geert Robaeys et al.
CLINICAL INFECTIOUS DISEASES (2013)
Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis (virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial
Mark Sulkowski et al.
LANCET INFECTIOUS DISEASES (2013)
Global control of hepatitis C: where challenge meets opportunity
David L. Thomas
NATURE MEDICINE (2013)
Challenges and opportunities for hepatitis C drug development in HIV-hepatitis C virus-co-infected patients
Vincent Soriano et al.
AIDS (2011)
Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort study
Pascal Melin et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs
Frederick L. Altice et al.
LANCET (2010)
Hepatitis C Treatment for Injection Drug Users: A Review of the Available Evidence
Margaret Hellard et al.
CLINICAL INFECTIOUS DISEASES (2009)
Share Paper
